Skip to Main Content

Paper Details

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood
2
2023
T-cell, aGVHD, abatacept, acute GVHD, cytomegalovirus or Epstein-Barr virus viremia, graft-versus-host disease, hematopoietic cell, patients
Author NameAffiliation
Donna NeubergDana-Farber Cancer Institute
Sung Won ChoiUniversity of Michigan ann arbor
Sung Won ChoiUniversity of Michigan ann arbor
  • 1 - 3

Datasets

Release 1.2